EARNING RECAP

Boeing Co.

#BA 2019 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q2 core EPS ($5.82) e st. $1.87 $15.80B est. $18.55B -3.12% ($361.43 closing price) $371.36 $360.03 Q2 total backlog of $474B; Cash marketable security of $9.60B
Q1 core EPS $3.16 est. $3.33 $22.9B est. $23.51B +.39% ($375.46 closing price) $381.15 $373.66 reports total backlog $487B; 2019 guidance does not reflect 737 MAX impact
#BA 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 core EPS $5.48 est. $4.58 $28.3B est. $26.87B +6.25% ($387.22 closing price) $391.97 $380.50 sees FY19 core EPS $19.90-$20.10 est. $18.31, FY19 revenue $109.5B-$111.5B est. $106.8B
Q3 core EPS $3.58 est. $3.47 $25.1B est. $23.98B +1.31% ($354.65 closing price) $364.60 $351.69 raises Fy18 core EPS view to $14.90- $15.10 from $14.30- $14.50, raises FY18 revenue view to $98B- $100B from $97B-$99B est. $98.53B
Q2 core EPS $3.33 est. $3.26 $24.3B est. $24.04B. -.66% ($355.92 closing) $356.30 $345.50 raises FY18 revenue to view to $97B-$99B est. $98B; raises FY18 Global Services revenue view to $15.5B-$16B from $15B -$15.5B; raises FY18 Defense, Space & Security revenue to $22B-$23B from $21.5B - $22.5B
Q1 core EPS $3.64 est. $2.58 $23.4B est. $22.24B +4.19% ($342.86 closing) $344.91 $330.52 raises FY18 core EPS view $14.30-$14.50 from $13.80-$14
#BA 2017 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 $4.80 may not compare to $2.89 $25.4 est. $24.69B +4.93% $360.97 $351.62 Fy18 core EPS $13.80-$14 may not compare to $11.96; revenue $96B-$98B
Q3 $2.72 vS $2.66 $24.3b VS $23.92b -2.85% closed at 258.42 $266.00 $254.50 Commercial Airplanes booked 117 net roders udring Q3
Q2 $2.25 vs.. $2.30 $22.74B vs. $23.02 +9.88%; $233.45 closing price $233.98 $223.02 Record high print. CEO believing better performance in every segment.
Q1 $2.01 vs. $1.93 $21Bil vs. $21.34Bil -.98% 183 181.71

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.